We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

77 hedge funds and large institutions have $421M invested in Translate Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 12

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

15% more funds holding

Funds holding: 67 → 77 (+10)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

19% less capital invested

Capital invested by funds: $521M → $421M (-$100M)

Holders
77
Holders Change
+10
Holders Change %
+14.93%
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
30
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.45M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.57M
3
RI
RTW Investments
New York
+$1.44M
4
Northern Trust
Northern Trust
Illinois
+$673K
5
State Street
State Street
Massachusetts
+$529K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$7.65M
2
MIM
Monashee Investment Management
Massachusetts
-$3.96M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.86M
4
DCM
DAFNA Capital Management
California
-$1.7M
5
HCM
Highbridge Capital Management
New York
-$1.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$129K +$3.96K +429 +3%
CSS
52
Cubist Systematic Strategies
Connecticut
$129K +$147K +15,889 New
GRP
53
Global Retirement Partners
California
$126K +$142K +15,425 New
Bank of America
54
Bank of America
North Carolina
$120K -$16.9K -1,833 -11%
Two Sigma Investments
55
Two Sigma Investments
New York
$115K +$131K +14,176 New
OAM
56
Oxford Asset Management
United Kingdom
$110K +$125K +13,551 New
Deutsche Bank
57
Deutsche Bank
Germany
$101K +$38.9K +4,214 +50%
Citigroup
58
Citigroup
New York
$98K -$7.65M -829,370 -99%
Mitsubishi UFJ Asset Management
59
Mitsubishi UFJ Asset Management
Japan
$97K +$119K +12,941 New
PP
60
Paloma Partners
Connecticut
$94K +$107K +11,552 New
Arrowstreet Capital
61
Arrowstreet Capital
Massachusetts
$94K +$107K +11,600 New
RJA
62
Raymond James & Associates
Florida
$89K -$80.1K -8,679 -44%
MIG
63
McGuire Investment Group
Rhode Island
$83K – – –
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$81.4K -$15.7K -1,701 -15%
Victory Capital Management
65
Victory Capital Management
Texas
$70K +$29.1K +3,152 +58%
Bank of Montreal
66
Bank of Montreal
Ontario, Canada
$41K +$16.6K +1,795 +57%
TRCT
67
Tower Research Capital (TRC)
New York
$34K +$38.5K +4,175 New
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$33K -$6.19K -671 -14%
RIA
69
Realta Investment Advisors
Delaware
$22K – – –
AIP
70
Ameritas Investment Partners
Nebraska
$20K – – –
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
$17K +$13.6K +1,470 +245%
Canada Life
72
Canada Life
Manitoba, Canada
$17K +$19.8K +2,145 New
PCM
73
Prelude Capital Management
New York
$13K +$14.8K +1,600 New
RWA
74
Ropes Wealth Advisors
Massachusetts
$8K – – –
Rockefeller Capital Management
75
Rockefeller Capital Management
New York
$4K – – –
1 2
3
4

TBIO Hedge Fund Activity: Q4 2019 in Review

77 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2019, worth a combined $421M — down 19% from $521M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TBIO positions and 8 closed out — a net gain of 10 holders — while 30 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $3.45M. The largest seller was Citigroup, cutting an estimated $7.65M.

  • 77 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2019, up from 67 in Q3 2019.
  • Funds reported $421M of Translate Bio, Inc. Common Stock stock for Q4 2019, down 19% quarter-over-quarter.
  • 18 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2019 and 8 closed out, a net change of +10 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q4 2019 was BlackRock, an estimated $3.45M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q4 2019 was Citigroup, an estimated $7.65M sold.

Based on aggregated 13F filings for Q4 2019.